GlassScriptPhysician profile
Netanel Benshalom
NPI 1902234768
$91,651.08
in general payments reported to CMS, 2019-2025
6 companies · $40K in 2025
The $40K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20K · 2023: $11K · 2024: $20K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $35K · Consulting Fee: $28K · Travel and Lodging: $5,434 · Royalty Or License: $2,822 · Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $34,565.75 |
| Consulting Fee | $28,017.64 |
| Travel and Lodging | $5,433.81 |
| Royalty Or License | $2,821.50 |
| Food and Beverage | $959.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Longeviti Neuro Solutions INC | $88,053.42 | 2022-2025 | Clearfit |
| Medtronic, INC. | $1,683.85 | 2022 | |
| Integra Lifesciences Corporation | $1,631.98 | 2024-2025 | Integra, Codman Certas, Cusa Clarity |
| Stryker Corporation | $154.59 | 2024-2025 | Vsp System, Vsp Cranial, Universal Neuro 3, Duramatrix |
| Novocure INC. | $110.13 | 2022-2023 | Optune |
| Meticuly INC. | $17.11 | 2024 | Meticuly Patient-Specific Titanium Mesh Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.01 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Netanel Benshalom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.